LncRNA Gm35585 transcriptionally activates the peroxidase EHHADH against diet-induced fatty liver
Open Access
- 13 March 2025
- journal article
- research article
- Published by Springer Nature in Experimental & Molecular Medicine
- Vol. 57 (3) , 652-666
Abstract
Metabolic-dysfunction-associated steatotic liver disease is one of the most common chronic liver diseases worldwide and has no approved treatment thus far. Here we report that the hepatic overexpression of Gm35585, a novel lncRNA downregulated in the livers of mice fed a high-fat diet, is functionally important in alleviating hepatic lipid accumulation pathologies. Gm35585 activates the peroxisome proliferator-activated receptor α (PPARα) signaling pathway and promotes the expression of downstream PPARα-target gene, enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase (EHHADH), which is one of the four enzymes of the peroxisomal β-oxidation pathway. Activation of EHHADH promotes the oxidation of long-chain fatty acids (LCFAs), and the increased levels of hepatic LCFAs contribute to metabolic-dysfunction-associated steatotic liver disease. Mechanistically, Gm35585 binds to retinoid X receptor α (RXRα) and then forms a PPARα/RXRα heterodimer with PPARα and guides the heterodimer to recognize the promoter of EHHADH, which is called peroxisome proliferator-activated receptor response element, causing transcriptional activation of EHHADH. Taken together, Gm35585 is a hepatic lipid metabolism regulator that activates EHHADH transcription, promoting peroxisomal β-oxidation of LCFAs and ultimately ameliorating diet-induced fatty liver.Keywords
Funding Information
- National Natural Science Foundation of China (81773827, 82304642)
- Natural Science Foundation of Jiangsu Province (BK20210430)
- China Postdoctoral Science Foundation (2020M681786)
This publication has 46 references indexed in Scilit:
- Long Noncoding RNA H19: A Key Player in Liver DiseasesHepatology, 2021
- Murine deficiency of peroxisomal l-bifunctional protein (EHHADH) causes medium-chain 3-hydroxydicarboxylic aciduria and perturbs hepatic cholesterol homeostasisCellular and Molecular Life Sciences, 2021
- Epidemiological Features of NAFLD From 1999 to 2018 in ChinaHepatology, 2020
- Effect of oleic acid on induction of steatosis and cytotoxicity in BRL 3A cellsJournal of Cellular Biochemistry, 2019
- A review of the molecular design and biological activities of RXR agonistsMedicinal Research Reviews, 2019
- Inhibition of lncRNA HULC improves hepatic fibrosis and hepatocyte apoptosis by inhibiting the MAPK signaling pathway in rats with nonalcoholic fatty liver diseaseJournal of Cellular Physiology, 2019
- The peroxisome: an update on mysteries 2.0Histochemistry and Cell Biology, 2018
- Human disorders of peroxisome metabolism and biogenesisBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2016
- Role of Dietary Fructose and Hepatic De Novo Lipogenesis in Fatty Liver DiseaseDigestive Diseases and Sciences, 2016
- Monounsaturated 14:1n‐9 and 16:1n‐9 Fatty Acids but not 18:1n‐9 Induce Apoptosis and Necrosis in Murine HL‐1 CardiomyocytesLipids, 2013